Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A well differentiated, low grade neuroendocrine tumor (carcinoid tumor) that arises from the ileum. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent.
Biomarker and diagnostic research for ileal neuroendocrine tumor G1 has been reported in the published literature.
3 clinical trials registered, 1 recruiting. Interventions under study include drug therapy and medical devices. Pipeline includes 1 PHASE3, 1 PHASE2, 1 NA. Research is sponsored by a mix of industry and academic institutions.
14 publications have been identified in PubMed for ileal neuroendocrine tumor G1. Research spans Case Report / Case Series (50%), Review / Meta-Analysis (14%), and Clinical Trial Publication (14%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:38 AM UTC
Research summaries | 2 | 14% |
Clinical study results | 2 | 14% |
Disease patterns and progression | 2 | 14% |
Testing and diagnosis research | 1 | 7% |
Shinkubo N (2026). [PMID: 42098036](https://pubmed.ncbi.nlm.nih.gov/42098036/). *Gan To Kagaku Ryoho*. [Case Report / Case Series]
Ocasio Quinones GA (2026). [PMID: 32809560](https://pubmed.ncbi.nlm.nih.gov/32809560/). *Unknown Journal*. [Review / Meta-Analysis]
Menon G (2026). [PMID: 28846286](https://pubmed.ncbi.nlm.nih.gov/28846286/). *Unknown Journal*. [Review / Meta-Analysis]
Rimawi A (2025). [PMID: 40621592](https://pubmed.ncbi.nlm.nih.gov/40621592/). *Oman medical journal*. [Case Report / Case Series]
Tayyab Z (2025). [PMID: 40291327](https://pubmed.ncbi.nlm.nih.gov/40291327/). *Cureus*. [Epidemiology / Natural History]
Irizarry SL (2025). [PMID: 40799664](https://pubmed.ncbi.nlm.nih.gov/40799664/). *Cureus*. [Clinical Trial Publication]
Lewetag RD (2025). [PMID: 41463158](https://pubmed.ncbi.nlm.nih.gov/41463158/). *Cancers*. [Diagnostic / Biomarker]
Asa SL (2024). [PMID: 39034742](https://pubmed.ncbi.nlm.nih.gov/39034742/). *The American journal of surgical pathology*. [Case Report / Case Series]
Lecoeur A (2024). [PMID: 39602485](https://pubmed.ncbi.nlm.nih.gov/39602485/). *European journal of endocrinology*. [Case Report / Case Series]
Romano E (2024). [PMID: 39064666](https://pubmed.ncbi.nlm.nih.gov/39064666/). *Nutrients*. [Epidemiology / Natural History]